Testoterone firm elects agencies

The Scottish pharma company is expected to launch its testosterone replacement therapy Tostran in the UK in the next two weeks.  Aimed at men aged 40 and over, Tostran is a prescription gel applied to the genital area.

Following a four-way battle,  Aquamarine will look after external comms, while Bedgebury Consulting will handle internal comms.

The  external PR campaign will raise awareness of the short and long-term health implications of testosterone deficiency,

Aquamarine founder Charlotte Messer will lead the programme, which will initially target GPs, and subsequent consumer work.